GLAB fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Gemina Laboratories Ltd. engages in the development of biotechnology in the In Vitro Diagnostics and human wellness monitoring market under the name “Gemina Labs.” Its products include LEGIO X, LEGIO XI, Respiratory Syncytial Virus, and Tuberculosis. The company was founded by Stephen John Davies and Robert Crandall Greene on October 10, 2017 and is headquartered in Burnaby, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
GLAB has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company